Votrient (pazopanib tablets) — Cigna
Thyroid Carcinoma, Differentiated
Initial criteria
- Patient age ≥ 18 years
- Patient has papillary OR follicular thyroid carcinoma refractory to radioactive iodine therapy OR patient has oncocytic carcinoma (formerly Hürthle cell carcinoma)
Approval duration
1 year